Upbeat earnings results and gains in high-growth stocks helped benchmarks close in the green on Tuesday. Merck, Sprint, Amreprise Financial and Cummins posted better-than-expected quarterly results. A fall in consumer confidence and rise in home prices had little impact on investor sentiment as they are now focusing on the outcome of the FOMC meeting on Wednesday.For a look at the […]
VOL. 129 | NO. 75 | Thursday, April 17, 2014
Guest Column
February Has Stock Market ‘Reboot’
REED WALTERS […]
Benchmarks finished in the green on Tuesday after blue-chip companies Coca-Cola and Johnson & Johnson reported upbeat quarterly results. Investors also remained focused on the recent developments in Ukraine. The day’s mixed economic data on urban consumer prices in March and a survey on manufacturing conditions for New York manufacturers in April had little impact on the benchmarks.For a look […]
Another day of selling pressure in bio-tech and technology stocks dragged the benchmarks down on Friday. Also, disappointing corporate earnings weighed on the markets. However, higher wholesale prices in March and an increase in preliminary consumer sentiment in April failed to restrict the day’s loss.For a look at the issues currently facing the markets, make sure to read today’s Ahead […]
Benchmarks soared on Wednesday primarily boosted by the encouraging minutes from the central bank’s policy meeting. Fed officials are said to be in favor of hiking rates only when they are sure about the economic recovery. Alcoa’s positive quarterly numbers boosted its share price, somewhat driving the broader market as well.For a look at the issues currently facing the markets, […]
Selling pressure in technology and momentum stocks dragged benchmarks down on Monday and the S&P 500 closed in the red for the year. Separately, biopharmaceutical company Pfizer weighed heavily on the Dow. The day’s economic report on consumer credit hardly influenced investors and they are now focusing on first quarter earnings reports.For a look at the issues currently facing the […]
Benchmarks snapped a four-day winning streak and ended lower on Thursday as investors adopted a wait and watch approach ahead of Friday’s nonfarm payroll data. Economic data came in mixed, hardly impacting the cautious stance of investors. These reports included better service sector data, higher weekly jobless claims and an increase in the U.S. trade deficit. Declines in bio-tech […]
Benchmarks ended lower on Thursday as investors feared sooner-than-expected rate hikes. Incidentally, the concerns emerged after the day’s mixed economic reports on fourth quarter GDP and weekly unemployment benefits. Declines in financial and technology stocks also dragged the markets lower. Eventually, the S&P 500 fell below the key technical level of 1,850 and the Nasdaq dropped to its lowest […]
Benchmarks ended in the red zone on Friday dragged by a fall in the bio-tech stocks and futures and options expiration. Investors also had to focus on the latest developments in the Crimea region. However, the indices ended the week with modest gains.For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall […]
Benchmarks erased initial losses to end Wednesday’s trading session on a mixed note. During the morning session, markets had slipped following a selloff in Asian and European equities over growing concerns about the Chinese economy. The lingering tension in Ukraine also dented the mood of the investors. However, the S&P 500 and Nasdaq entered the positive territory late in the […]
